LifePoint Health (LPNT) Receiving Positive Press Coverage, Analysis Shows
Media headlines about LifePoint Health (NASDAQ:LPNT) have trended positive on Saturday, Accern reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. LifePoint Health earned a media sentiment score of 0.40 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.6992506328373 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Shares of LifePoint Health (NASDAQ LPNT) opened at $49.60 on Friday. The company has a debt-to-equity ratio of 1.24, a quick ratio of 1.65 and a current ratio of 1.85. LifePoint Health has a 1 year low of $42.50 and a 1 year high of $70.95. The firm has a market capitalization of $1,810.00, a P/E ratio of 11.75, a P/E/G ratio of 1.12 and a beta of 0.67.
LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings results on Friday, October 27th. The company reported $0.80 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.95 by ($0.15). LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The firm had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.60 billion. During the same quarter in the prior year, the firm earned $0.94 earnings per share. The company’s revenue for the quarter was down .7% compared to the same quarter last year. research analysts predict that LifePoint Health will post 3.64 EPS for the current fiscal year.
A number of brokerages have recently weighed in on LPNT. BidaskClub upgraded LifePoint Health from a “sell” rating to a “hold” rating in a research report on Thursday. Raymond James Financial reiterated a “market perform” rating on shares of LifePoint Health in a research report on Monday, October 30th. Robert W. Baird set a $55.00 price objective on LifePoint Health and gave the stock a “buy” rating in a research report on Monday, October 30th. Credit Suisse Group began coverage on LifePoint Health in a research report on Thursday, November 2nd. They issued a “neutral” rating and a $54.00 price objective on the stock. Finally, William Blair reiterated an “outperform” rating on shares of LifePoint Health in a research report on Tuesday, November 21st. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and five have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $59.14.
In related news, Director Marguerite Kondracke sold 3,907 shares of LifePoint Health stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $44.73, for a total transaction of $174,760.11. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 8.76% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece was published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are viewing this piece on another website, it was illegally copied and reposted in violation of United States and international copyright & trademark laws. The original version of this piece can be accessed at https://theolympiareport.com/2018/01/13/lifepoint-health-lpnt-receiving-positive-press-coverage-analysis-shows.html.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.